View analysts' price targets and recommendations, and compare them with competitors.
$207.00
Analysts expect the stock price to increase by 16.41%.
Buy
Positive consensus among analysts.
Analyze DCF forecasts for the company and compare them with competitors.
16.68B
Revenue has increased from the previous period.
52.73%
Revenue growth rate has increased from the previous period.
5.69B
EBITDA has increased from the previous period.
34.13%
EBITDA margin has increased from the previous period.
4.59B
EBIT has increased from the previous period.
27.54%
EBIT margin has decreased from the previous period.
1.10B
Depreciation has increased from the previous period.
11.56B
Total cash has increased from the previous period.
69.33%
Cash percentage has decreased from the previous period.
2.43B
Receivables have increased from the previous period.
14.57%
Receivables percentage has decreased from the previous period.
1.83B
Inventories have increased from the previous period.
10.95%
Inventory percentage has increased from the previous period.
1.15B
Accounts payable has increased from the previous period.
6.89%
Payables percentage has increased from the previous period.
-1.13B
Capital expenditure has increased from the previous period.
-6.76%
CapEx percentage has increased from the previous period.
12.06%
WACC has increased from the previous period.
12.08%
Cost of equity is unchanged from the previous period.
4.26%
Cost of debt is unchanged from the previous period.
1.66
Beta is unchanged from the previous period.
24.94B
Diluted shares outstanding is unchanged from the previous period.
11.06B
Total debt is unchanged from the previous period.
3.35T
Total equity is unchanged from the previous period.
3.36T
Total capital is unchanged from the previous period.
0.33%
Debt weighting is unchanged from the previous period.
99.67%
Equity weighting is unchanged from the previous period.
4.51B
EBIAT has increased from the previous period.
3.33B
UFCF has increased from the previous period.
4.00%
Long-term growth rate is unchanged from the previous period.
1.62T
Terminal value is unchanged from the previous period.
1.12T
Enterprise value has decreased from the previous period.
3.78B
Net debt is unchanged from the previous period.
1.12T
Equity value has decreased from the previous period.
44.94
Equity value per share is unchanged from the previous period.
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Analyze analyst forecasts for the company and compare them with competitors.
59.31B
The estimated revenue has increased from the previous period.
8.40B
The estimated EBITDA has increased from the previous period.
1.24
The estimated EPS has increased from the previous period.
6.96B
The estimated net income has decreased from the previous period.
7.22B
The estimated EBIT has increased from the previous period.
2.12B
The estimated SG&A expenses have increased from the previous period.
